Physician profile
Lillian Devito
NPI 1336599091
$1,314.25
in general payments reported to CMS, 2019-2025
17 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.53 · 2022: $202 · 2023: $304 · 2024: $306 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $453.97 | 2021-2025 | Kisqali, Piqray |
| Abbvie INC. | $158.98 | 2022-2025 | |
| Janssen Biotech, INC. | $137.13 | 2022-2025 | Darzalex, Tecvayli, Talvey |
| Genzyme Corporation | $121.21 | 2024-2025 | |
| Pfizer INC. | $63.79 | 2022-2025 | |
| Genentech USA, INC. | $61.76 | 2023-2025 | Tecentriq Hybreza, Venclexta |
| Astellas Pharma US INC | $56.28 | 2022-2023 | Xospata |
| Glaxosmithkline, LLC. | $42.82 | 2023 | Zejula, Jemperli |
| Emd Serono, INC. | $32.62 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $32.10 | 2021-2022 | |
| Mirati Therapeutics, INC. | $27.01 | 2023 | Krazati |
| E.R. Squibb & Sons, L.L.C. | $24.91 | 2024 | Opdivo |
| Eisai INC. | $24.49 | 2024 | |
| Recordati_rare_diseases_inc. | $22.42 | 2024 | Sylvant |
| Regeneron Healthcare Solutions, INC. | $22.32 | 2025 | Lynozyfic |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Puma Biotechnology, INC. | $20.00 | 2024 | |
| Dova Pharmaceuticals | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lillian Devito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.